Ellen Meijer

3.1k total citations
62 papers, 2.1k citations indexed

About

Ellen Meijer is a scholar working on Hematology, Oncology and Epidemiology. According to data from OpenAlex, Ellen Meijer has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 16 papers in Oncology and 15 papers in Epidemiology. Recurrent topics in Ellen Meijer's work include Hematopoietic Stem Cell Transplantation (25 papers), Cytomegalovirus and herpesvirus research (13 papers) and Viral-associated cancers and disorders (12 papers). Ellen Meijer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Cytomegalovirus and herpesvirus research (13 papers) and Viral-associated cancers and disorders (12 papers). Ellen Meijer collaborates with scholars based in Netherlands, Italy and Germany. Ellen Meijer's co-authors include Leo F. Verdonck, Jan J. Cornelissen, Bronno van der Holt, Bob Löwenberg, Sacco C. de Vries, Joost W. J. van Esser, Hubert G.M. Niesters, Albert D. M. E. Osterhaus, Jan W. Gratama and Marijke Hartog and has published in prestigious journals such as Blood, The Plant Cell and Clinical Microbiology Reviews.

In The Last Decade

Ellen Meijer

61 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ellen Meijer Netherlands	23	871	647	552	489	417	62	2.1k
Markus Kapp Germany	20	315 0.4×	251 0.4×	306 0.6×	237 0.5×	92 0.2×	51	1.0k
Vladimir Lazarević Sweden	23	216 0.2×	845 1.3×	91 0.2×	990 2.0×	95 0.2×	86	2.1k
Jeane Eliete Laguila Visentainer Brazil	27	65 0.1×	557 0.9×	428 0.8×	302 0.6×	39 0.1×	157	2.2k
Rachel Ehrlich Israel	24	188 0.2×	150 0.2×	290 0.5×	544 1.1×	75 0.2×	68	1.6k
Jose J. Limon United States	14	116 0.1×	102 0.2×	322 0.6×	1.1k 2.3×	54 0.1×	19	1.8k
Zaher Hanna Canada	23	161 0.2×	61 0.1×	268 0.5×	705 1.4×	54 0.1×	49	2.1k
N. Kirby Alton United States	13	887 1.0×	525 0.8×	163 0.3×	698 1.4×	79 0.2×	20	2.1k
David A. Bergin Ireland	17	182 0.2×	100 0.2×	118 0.2×	371 0.8×	84 0.2×	27	1.6k
Y. Kletter Israel	21	203 0.2×	150 0.2×	199 0.4×	296 0.6×	16 0.0×	48	1.3k
Johan Van Weyenbergh Brazil	26	108 0.1×	141 0.2×	542 1.0×	278 0.6×	45 0.1×	71	1.6k

Countries citing papers authored by Ellen Meijer

Since Specialization

Citations

This map shows the geographic impact of Ellen Meijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Meijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Meijer more than expected).

Fields of papers citing papers by Ellen Meijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Meijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Meijer. The network helps show where Ellen Meijer may publish in the future.

Co-authorship network of co-authors of Ellen Meijer

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Meijer. A scholar is included among the top collaborators of Ellen Meijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Meijer. Ellen Meijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Piemontese, Simona, Myriam Labopin, Goda Choi, et al.. (2024). Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide. Leukemia. 38(9). 2016–2022. 1 indexed citations

Leeuw, David C. de, Caroline E. Rutten, Otto Visser, et al.. (2023). ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non‐myeloablative conditioning. British Journal of Haematology. 203(3). 439–445. 2 indexed citations

Meijer, Ellen, et al.. (2022). The 48th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians - Oral Sessions (O009-O155). Bone Marrow Transplantation. 57(S1). 16–99. 3 indexed citations

Rolling, Thierry, Gabriel K. Armijo, Bing Zhai, et al.. (2022). Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study. Transplantation and Cellular Therapy. 29(1). 63.e1–63.e5. 3 indexed citations

Knoop, Hans, Floor Bennebroek Evertsz, Sanne H. Booij, et al.. (2021). Personalized versus standard cognitive behavioral therapy for fear of cancer recurrence, depressive symptoms or cancer-related fatigue in cancer survivors: study protocol of a randomized controlled trial (MATCH-study). Trials. 22(1). 696–696. 5 indexed citations

Geneugelijk, Kirsten, Hanneke W. M. van Deutekom, Jorg J. A. Calis, et al.. (2019). Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations. Frontiers in Immunology. 10. 880–880. 14 indexed citations

Ruggeri, Annalisa, Myriam Labopin, Andrea Bacigalupo, et al.. (2018). Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. Journal of Hematology & Oncology. 11(1). 40–40. 97 indexed citations

Meijer, Ellen, et al.. (2014). Pressure mat analysis of the longitudinal development of pig locomotion in growing pigs after weaning. BMC Veterinary Research. 10(1). 37–37. 29 indexed citations

Oosterom, A. van, et al.. (2012). Adequate control of primary EBV infection and subsequent reactivations after cardiac transplantation in an EBV seronegative patient. Transplant Immunology. 27(1). 48–51. 5 indexed citations

10.

Dorp, Suzanne van, Monique C. Minnema, Jürgen Kuball, et al.. (2011). Influence of Donor Cytomegalovirus (CMV) Status on Severity of Viral Reactivation after Allogeneic Stem Cell Transplantation in CMV-Seropositive Recipients. Clinical Infectious Diseases. 52(7). e144–e148. 17 indexed citations

11.

Dorp, Suzanne van, Matthias Wölfl, Leo F. Verdonck, et al.. (2009). Rituximab Treatment before Reduced-Intensity Conditioning Transplantation Associates with a Decreased Incidence of Extensive Chronic GVHD. Biology of Blood and Marrow Transplantation. 15(6). 671–678. 29 indexed citations

12.

Meijer, Ellen & Jan J. Cornelissen. (2008). Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients. Current Opinion in Hematology. 15(6). 576–585. 28 indexed citations

13.

Meijer, Ellen, Sanne Spijkers, Greet J. Boland, et al.. (2005). Active Epstein–Barr virus infection after allogeneic stem cell transplantation: re‐infection or reactivation?. Transplant Infectious Disease. 7(1). 4–10. 12 indexed citations

14.

Meijer, Ellen, A. W. Dekker, H M Lokhorst, et al.. (2004). Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation. Transplant Infectious Disease. 6(4). 171–178. 27 indexed citations

15.

Meijer, Ellen, Jan J. Cornelissen, Bob Löwenberg, & Leo F. Verdonck. (2003). Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell—depleted grafts from matched unrelated donors: A dose-finding study. Experimental Hematology. 31(11). 1026–1030. 30 indexed citations

16.

Thijsen, Steven, Ellen Meijer, Hubert G.M. Niesters, et al.. (2003). Sequence analysis of EBV DNA isolated from mouth washings and PBMCs of healthy individuals and blood of EBV-LPD patients. Journal of Clinical Virology. 28(1). 85–92. 13 indexed citations

17.

Meijer, Ellen, A. W. Dekker, & Leo F. Verdonck. (2003). Influence of antithymocyte globulin dose on outcome in cytomegalovirus‐seropositive recipients of partially T cell‐depleted stem cell grafts from matched‐unrelated donors. British Journal of Haematology. 121(3). 473–476. 11 indexed citations

18.

Engelen, Fred A. van, A.J. de Jong, Ellen Meijer, et al.. (1995). Purification, immunological characterization and cDNA cloning of a 47 kDa glycoprotein secreted by carrot suspension cells. Plant Molecular Biology. 27(5). 901–910. 12 indexed citations

19.

Meijer, Ellen, Sacco C. de Vries, Peter Sterk, et al.. (1993). Characterization of the non-specific lipid transfer protein EP2 from carrot (Daucus carota L.). Molecular and Cellular Biochemistry. 123(1-2). 159–166. 43 indexed citations

20.

Noort, Daan, Ellen Meijer, T.J. Visser, et al.. (1991). Selective inhibition of glucuronidation by 2,2,2-triphenylethyl-UDP in isolated rat hepatocytes: conjugation of harmol, 3,3',5-triiodothyronine, and N-hydroxy-2-acetylaminofluorene.. Molecular Pharmacology. 40(2). 316–320. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact